RIEMSER Introduces Bacterin Line of Allograft Products to US Dental Market

Summary:

RIEMSER Dental, a leading supplier of bone regeneration products, will begin distributing the Bacterin family of dental allograft products to general dentists, periodontists, and oral and maxillofacial surgeons.

Full Article:

* OsteoSponge® Block, a novel, cancellous demineralized bone matrix (DBM) that can absorb its weight in fluid and has the malleability and elasticity to be compressed into any void, while forming a strong biological scaffold

* OsteoSponge® Filler, a unique demineralized particulate allograft that provides excellent osteoinduction

* D-Block, a novel sterilized block allograft for alveolar defects

* OsteoWrap®, a flexible 100% human cortical bone product that offers unique malleability, while acting as a barrier membrane

These products are indicated for ridge augmentations, sinus elevations, and repair of other bony defects where allograft products can enhance bone-grafting procedures. U.S. surgeons have been using the Bacterin line successfully in dental, spinal, and orthopedic procedures for the past five years.

“We’re very pleased that RIEMSER will help expand the use of Bacterin’s OsteoSponge line within the dental market,” said Jesus Hernandez, Vice President of Biologics for Bacterin International. “Surgeons worldwide recognize the multi-surgical uses and added benefits of OsteoSponge DBM in bone regeneration.”

RIEMSER Dental, based in Research Triangle Park, North Carolina, has a product portfolio that also includes Cerasorb® M grafting material, EpiGuide® membrane, and REVOIS® implant products.